JCVI issues updated COVID-19 Booster advice – AstraZeneca vaccine can be considered for those who had it previously due to allergies
- 16 September 2021
- News
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on the COVID-19 vaccine booster programme.
The full announcement can be read here :- JCVI Issues updated advice on COVID-19 booster vaccination
Of particular note for people with allergies who were previously advised to have the AstraZeneca vaccine the announcement states :-
‘The JCVI advises a preference for the Pfizer-BioNTech vaccine for the booster programme, regardless of which vaccine brand someone received for their primary doses. This follows data from the COV-BOOST trial that indicates the Pfizer-BioNTech vaccine is well tolerated as a third dose and provides a strong booster response.
Alternatively, a half dose of the Moderna vaccine may be offered. Where mRNA vaccines cannot be offered, for example due to allergies, the AstraZeneca vaccine may be considered for those who received it previously.’
If you have an allergy and have questions about the booster program or COVID-19 vaccination please see our FAQ here :- COVID-19 Vaccines FAQ
You can also call the Anaphylaxis Campaign helpline on 01252 542029 Monday – Friday 9am-5pm
